Factor D Inhibitors (Novartis)

N/A

Report date: 2025/01/26 18:04:44
NME

Base Information

Drug NameFactor D Inhibitors (Novartis)
Drug Alias NameComplement Factor D Inhibitors (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsHemoglobinuria, ParoxysmalHemolytic-Uremic SyndromeGlomerulonephritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research IncNovartis Pharma Ag
Inactive CompaniesNovartis Ag
Active IndicationsHemoglobinuria, ParoxysmalHemolytic-Uremic SyndromeGlomerulonephritis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A